Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ADACCESS: GP2017 vs Humira in Plaque Psoriasis
NCT02016105Phase 3Completed
- Sponsor
- Sandoz
- Start
- Dec 2013
- Primary completion
- Jul 2015
- Modality
- Monoclonal Antibodies
- Countries
- 4
01
Overview
A Phase 3 trial of adalimumab-adaz in plaque psoriasis, sponsored by Sandoz. Started Dec 2013; status: completed.
02
Drugs
adalimumab-adaz
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT02016105.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02016105.